Free Trial

Agios Pharmaceuticals (AGIO) SEC Filings & 10K Form

Agios Pharmaceuticals logo
$53.78 -1.62 (-2.92%)
(As of 11/15/2024 ET)

Recent Agios Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/13/2024
3:14 PM
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
3:17 PM
Agios Pharmaceuticals (Subject)
Ballal Rahul D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
1:40 PM
Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
10/31/2024
8:20 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
5:56 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:15 PM
Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:12 PM
Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:15 PM
Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:15 PM
Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
8:49 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
6:03 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
3:30 PM
Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:06 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:29 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:31 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:32 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:13 PM
Agios Pharmaceuticals (Issuer)
CAPELLO JEFFREY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:15 PM
Agios Pharmaceuticals (Issuer)
Owen Catherine E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:18 PM
Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:19 PM
Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:20 PM
Agios Pharmaceuticals (Issuer)
Smith Cynthia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:22 PM
Agios Pharmaceuticals (Issuer)
Ballal Rahul D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:50 PM
Agios Pharmaceuticals (Subject)
Goff Brian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
3:14 PM
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
6:09 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
8:20 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2024
6:01 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:03 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:47 PM
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:49 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:26 PM
Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
5:05 PM
Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:06 PM
Agios Pharmaceuticals (Subject)
Foster-Cheek Kaye I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
8:21 PM
Agios Pharmaceuticals (Subject)
Schenkein David P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
4:43 PM
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
9:33 AM
Agios Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
6:03 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
4:50 PM
Agios Pharmaceuticals (Issuer)
Agios Pharmaceuticals (Issuer)
Washburn Theodore James Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:21 PM
Agios Pharmaceuticals (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/13/2024
5:07 AM
Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G/A
02/12/2024
10:21 AM
Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
There is a little known company that is changing warfare (Ad)

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t
02/12/2024
9:50 AM
Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2024
10:39 AM
Agios Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
01/24/2024
3:20 PM
Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:22 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:23 PM
Agios Pharmaceuticals (Issuer)
Jones Cecilia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:24 PM
Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
3:25 PM
Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
11:37 AM
Agios Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/09/2024
3:25 PM
Agios Pharmaceuticals (Issuer)
Burns James William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:26 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:28 PM
Agios Pharmaceuticals (Issuer)
Goff Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:22 PM
Agios Pharmaceuticals (Issuer)
Gheuens Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:58 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:10 PM
Agios Pharmaceuticals (Issuer)
Milanova Tsveta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AGIO) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners